Volume 10, Issue 5, Pages (February 2015)

Slides:



Advertisements
Similar presentations
DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation
Advertisements

Joseph H. Chewning, Weiwei Zhang, David A. Randolph, C
Host-Derived CD8+ Dendritic Cells Protect Against Acute Graft-versus-Host Disease after Experimental Allogeneic Bone Marrow Transplantation  Michael Weber,
Volume 45, Issue 5, Pages (November 2016)
IL-2–Targeted Therapy Ameliorates the Severity of Graft-versus-Host Disease: Ex Vivo Selective Depletion of Host-Reactive T Cells and In Vivo Therapy 
Identification of Stem Cell Transcriptional Programs Normally Expressed in Embryonic and Neural Stem Cells in Alloreactive CD8+ T Cells Mediating Graft-versus-Host.
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
Volume 136, Issue 4, Pages e3 (April 2009)
Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease by Yi Zhang, Ashley R. Sandy, Jina Wang,
Ping Zhang, Jieying Wu, Divino Deoliveira, Nelson J. Chao, Benny J
Apoptotic Donor Leukocytes Limit Mixed-Chimerism Induced by CD40-CD154 Blockade in Allogeneic Bone Marrow Transplantation  Jian-ming Li, John Gorechlad,
Feedback Regulation of Pathogen-Specific T Cell Priming
Volume 44, Issue 1, Pages (January 2016)
Ikaros-Notch axis in host hematopoietic cells regulates experimental graft-versus-host disease by Tomomi Toubai, Yaping Sun, Isao Tawara, Ann Friedman,
Ex Vivo Rapamycin Generates Th1/Tc1 or Th2/Tc2 Effector T Cells With Enhanced In Vivo Function and Differential Sensitivity to Post-transplant Rapamycin.
Culture expanded primary chondrocytes have potent immunomodulatory properties and do not induce an allogeneic immune response  P. Lohan, O. Treacy, K.
LBH589 Enhances T Cell Activation In Vivo and Accelerates Graft-versus-Host Disease in Mice  Dapeng Wang, Cristina Iclozan, Chen Liu, Changqing Xia, Claudio.
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi.
Hans-Peter Raué, Carol Beadling, Jennifer Haun, Mark K. Slifka 
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer.
The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease by Shan He, Fang.
by Sheng F. Cai, Xuefang Cao, Anjum Hassan, Todd A
Human CD4+CD25+ Cells in Combination with CD34+ Cells and Thymoglobulin to Prevent Anti-hematopoietic Stem Cell T Cell Alloreactivity  Dolores Mahmud,
miR-150-Mediated Foxo1 Regulation Programs CD8+ T Cell Differentiation
Volume 18, Issue 1, Pages (January 2017)
CD134-Allodepletion Allows Selective Elimination of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific Effectors  Xupeng.
Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets by Maria Nikolova, Jean-Daniel Lelievre, Matthieu.
IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease after Bone Marrow Transplantation  Lucrezia Colonna, Mareike.
Evelyn C. Nieves, Tomomi Toubai, Daniel C
Pharmacologic Expansion of Donor-Derived, Naturally Occurring CD4+Foxp3+ Regulatory T Cells Reduces Acute Graft-versus-Host Disease Lethality Without.
The Triterpenoid CDDO-Me Delays Murine Acute Graft-versus-Host Disease with the Preservation of Graft-versus-Tumor Effects after Allogeneic Bone Marrow.
Minor Antigen Distribution Predicts Site-Specific Graft-versus-Tumor Activity of Adoptively Transferred, Minor Antigen-Specific CD8 T Cells  Jessica C.
An Essential Role for IFN-γ in Regulation of Alloreactive CD8 T Cells Following Allogeneic Hematopoietic Cell Transplantation  Wannee Asavaroengchai,
Survival and Function of MiHA Epitope-Specific Host CD8 TM Cells Following Ablative Conditioning and HCT  Alwi M. Shatry, Derry C. Roopenian, Robert B.
Blocking Activator Protein 1 Activity in Donor Cells Reduces Severity of Acute Graft- Versus-Host Disease through Reciprocal Regulation of IL-17–Producing.
Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice  Yongxia Wu, David Bastian, Steven Schutt, Hung Nguyen,
T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease  Cristina Iclozan, Yu Yu, Chen Liu, Yaming Liang, Tangsheng.
Volume 22, Issue 2, Pages (February 2005)
Volume 18, Issue 3, Pages (March 2003)
Volume 25, Issue 3, Pages (September 2006)
T Cell and B Cell Immunity can be Reconstituted with Mismatched Hematopoietic Stem Cell Transplantation Without Alkylator Therapy in Artemis-Deficient.
The Triterpenoid CDDO-Me Delays Murine Acute Graft-versus-Host Disease with the Preservation of Graft-versus-Tumor Effects after Allogeneic Bone Marrow.
Volume 33, Issue 1, Pages (July 2010)
Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease  Isao Tawara,
A Radio-Resistant Perforin-Expressing Lymphoid Population Controls Allogeneic T Cell Engraftment, Activation, and Onset of Graft-versus-Host Disease in.
Dynamic Change and Impact of Myeloid-Derived Suppressor Cells in Allogeneic Bone Marrow Transplantation in Mice  Dapeng Wang, Yu Yu, Kelley Haarberg,
Volume 35, Issue 5, Pages (November 2011)
Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation 
Volume 28, Issue 6, Pages (June 2008)
Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host.
In Situ Activation and Expansion of Host Tregs: A New Approach to Enhance Donor Chimerism and Stable Engraftment in Major Histocompatibility Complex-Matched.
Dynamics of Blood-Borne CD8 Memory T Cell Migration In Vivo
Volume 29, Issue 6, Pages (December 2008)
Volume 33, Issue 4, Pages (October 2010)
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  Axel Kallies, Annie Xin, Gabrielle T.
Volume 19, Issue 3, Pages (September 2003)
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells  Weiguo Cui, Ying Liu, Jason S. Weinstein,
Volume 42, Issue 1, Pages (January 2015)
Volume 17, Issue 2, Pages (February 2009)
Volume 41, Issue 1, Pages (July 2014)
Volume 14, Issue 5, Pages (February 2016)
Volume 46, Issue 4, Pages (April 2017)
Raimon Duran-Struuck, Isao Tawara, Kathi Lowler, Shawn G
Volume 32, Issue 1, Pages (January 2010)
Volume 22, Issue 8, Pages (February 2018)
Volume 25, Issue 1, Pages (July 2006)
Volume 13, Issue 11, Pages (December 2015)
Pretreatment of donor T cells with a c-Rel antagonist does not impair GVT activity. Pretreatment of donor T cells with a c-Rel antagonist does not impair.
Volume 37, Issue 2, Pages (August 2012)
Presentation transcript:

Volume 10, Issue 5, Pages 702-710 (February 2015) Immunomodulation of Selective Naive T Cell Functions by p110δ Inactivation Improves the Outcome of Mismatched Cell Transplantation  Jean-Marc Doisne, Christian M. Hüber, Klaus Okkenhaug, Francesco Colucci  Cell Reports  Volume 10, Issue 5, Pages 702-710 (February 2015) DOI: 10.1016/j.celrep.2015.01.002 Copyright © 2015 The Authors Terms and Conditions

Cell Reports 2015 10, 702-710DOI: (10.1016/j.celrep.2015.01.002) Copyright © 2015 The Authors Terms and Conditions

Figure 1 Inactivation of p110δ Reduces GvHD Severity and Impairs Allogeneic T Cell Functions In Vivo (A) Survival curve of two combined independent experiments where lethally irradiated BALB/c hosts were intravenously (i.v.) injected with either 5 × 106 TCD-BMCs only (BM group, n = 10) or 5 × 106 TCD-BMCs and 1 × 106 control T cells (WT T group, n = 10) or 1 × 106 D910A T cells (D910A T group, n = 10). The difference in survival between the two latter groups is significant (p = 0.02; Mantel-Cox test). The graph on the right panel shows the combined results of two independent experiments quantifying GvHD clinical score of BALB/c mice receiving p110δWT/D910A (control) T cells (gray column; n = 10) or D910A T cells (white column; n = 7) evaluated at the endpoint (loss of 20% bodyweight) (mean ± range, unpaired t test). (B) Spleens from lethally irradiated BALB/c mice injected with allogeneic T cells from WT (WT T group) or D910A (D910A T group) mice were harvested at day 3, 4, and 5. Absolute numbers of donor T cells were calculated on the basis of flow cytometry analysis (n = 3–5; mean ± range; unpaired t test; ∗p = 0.029, ∗∗∗p = 0.001). (C) Representative dot plots of CD4+ and CD8+ T cell differentiation profile based on CD62L and CD44 expression 4 days after hematopoietic cell transplantation (HCT). (D) At day 5, allogeneic CD8+ T cells from WT (solid line) or D910A (dotted line) mice were analyzed for GzmB expression by flow cytometry. Data are from one experiment with n = 5 mice in each group (mean ± range, unpaired t test). (E) The percentage of CD4+ (left) and CD8+ (right) Tregs were assessed at day 5 post-HCT based on the expression of FoxP3 measured by intracellular flow cytometry (n = 5; mean ± range; unpaired t test). Cell Reports 2015 10, 702-710DOI: (10.1016/j.celrep.2015.01.002) Copyright © 2015 The Authors Terms and Conditions

Figure 2 Inactivation of p110δ Preserves GvL Lethally irradiated BALB/c hosts were i.v. injected with 5 × 106 TCD-BMCs and 5 × 104 A20 (lymphoma) cells (A20 group, n = 12), 5 × 106 TCD-BMCs plus 5 × 104 A20 cells in the presence of B6 T cells from either WT (WT T group, n = 12) or D910A (D910A T group, n = 9) mice. The endpoint for this experiment was 25% weight loss, rather than 20% as in Figure 1. The p value (Mantel-Cox test) indicates statistical difference between the WT T group and the D910A T group. Data are from two experiments with n = 4–8 mice in each group. Cell Reports 2015 10, 702-710DOI: (10.1016/j.celrep.2015.01.002) Copyright © 2015 The Authors Terms and Conditions

Figure 3 Inactivation of p110δ Inhibits Allogeneic Naive T Cell Proliferation and Differentiation In Vitro (A and B) B6 sorted naive and memory T cells were labeled with CFSE and cocultured with LPS-matured and irradiated BALB/c BMDCs at a 1:1 ratio with DMSO vehicle control or the indicated doses of IC87114 (IC) or LY294002 (LY). At day 5, proliferation (A) and differentiation (B) of CD8+ T cells were quantified. Differentiation phenotype is based on CD62L and CD44 expression as follows: naive (Tn; CD62L+CD44lo), central memory-like (Tcm; CD62L+CD44hi), and effector memory-like (Tem; CD62L−CD44hi). Results are representative of three independent experiments. (C–F) T cells come from the cultured alloreactive T cells generated in vitro in presence of DMSO or IC. These cells were stimulated first with irradiated BALB/c BMDCs loaded with A20 lysate for 5 days, then expanded with anti-CD3 and anti-CD28 + rmIL-2/rmIL-7 for 2 days and maintained in a low dose of rmIL-2 and rmIL-7 in the presence of DMSO or IC during the whole process. The level of GzmB (D) and P-Akt (E) were assessed at the end of this process. (C) After 5 days of priming, Tn and memory (Tm, CD44hi) T cell absolute numbers were evaluated. Tn/Tm ratios were calculated either in DMSO or in IC (5 μM) (left), and DMSO/IC ratios were determined for each subset (right). Results are from four independent experiments (mean ± range, paired t test). (D) GzmB expression was assessed in Tn and in Tm primed and expanded in the presence of DMSO (solid line) or IC (dotted line). Results are representative of three independent experiments. (E) Tn and Tm cultured in the presence of DMSO (solid line) or IC (dotted line) were stained for P-Akt (Ser473) or P-Akt (Thr308) and analyzed by flow cytometry. Results are representative of two independent experiments. (F) Tn (top) or Tm (bottom) cultured in the presence of DMSO (solid line) or IC (dotted line) were stimulated for 5 hr with A20 cells (left) or A20-pulsed BALB/c BMDCs (right). Intracellular IFN-γ was stained and analyzed by flow cytometry. The percentages and geometric mean fluorescence intensities (GMFIs) of IFN-γ+ cells are depicted on each histogram. Data are representative of two independent experiments. See also Figure S1. Cell Reports 2015 10, 702-710DOI: (10.1016/j.celrep.2015.01.002) Copyright © 2015 The Authors Terms and Conditions

Figure 4 Inactivation of p110δ Inhibits Allogeneic Naive T Cells In Vivo Lethally irradiated BALB/c hosts were i.v. injected with 5 × 106 TCD-BMCs and 5 × 104 A20 (lymphoma) cells (A20 group, n = 9), 5 × 106 TCD-BMCs plus 5 × 104 A20 cells in the presence of B6 naive T cells (1 × 106 cells) from either WT (WT Tn group, n = 14) or D910A (D910A Tn group, n = 12) mice, or in the presence of B6 memory T cells (0.5 × 106 cells) from either WT (WT Tm group, n = 6) or D910A (D910A Tm group, n = 5). The table summarizes the cause of death for each group: acute GvHD (≤7 days), delayed GvHD (>7 days), tumor (<21 days), or delayed tumor (>21 days). The last column shows the overall survival rate at day 91. The endpoint for this experiment was 25% weight loss. The p values (Mantel-Cox test) compare the WT Tn group with the D910A Tn group and the WT Tm group with the D910A Tm group. Data are from two experiments with n = 5–14 mice in each group. See also Figure S2. Cell Reports 2015 10, 702-710DOI: (10.1016/j.celrep.2015.01.002) Copyright © 2015 The Authors Terms and Conditions

Figure 5 Inactivation of p110δ Inhibits Allogeneic Human T Cell Activation (A) Healthy donor PBMCs were labeled with CFSE and cocultured with stimulator cells, i.e., irradiated PBMCs from another healthy donor. Mixed lymphocyte cultures at 1:1 ratio were set up in the presence of DMSO vehicle control, IC (10 μM), or LY (10 μM). After 6 days, proliferation of allogeneic T cells was quantified by enumerating the % of CFSElow cells. The histogram graph represents five combinations of responding and stimulator cells from five individual healthy donors whose identity is marked by a capital letter. (B) A similar experiment was performed using sorted naive and memory T cells from four different donors as responder cells. (C) Granzyme B expression (GMFI) was measured by flow cytometry in CD8+ allogeneic T cells at day 6 of the MLR assay. Histograms are representative of two independent experiments. Cell Reports 2015 10, 702-710DOI: (10.1016/j.celrep.2015.01.002) Copyright © 2015 The Authors Terms and Conditions